Harvard Medical School is re-evaluating rigid conflict-of-interest rules that aim to shield scientific research from corporate influence amid complaints by some professors that the restrictions slow the process of turning discoveries into research tools and treatments. Eric Campbell (Mass General), Donald Ingber (Wyss Institute), Marcia Angell (HMS) and Charles Serhan (Brigham and Women’s) are quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?